Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum.
Black or African American
/ statistics & numerical data
Aged
Asian
/ statistics & numerical data
COVID-19
/ epidemiology
Cohort Studies
Communicable Disease Control
/ standards
Female
Genital Neoplasms, Female
/ diagnosis
Gynecology
/ organization & administration
Healthcare Disparities
/ statistics & numerical data
Hispanic or Latino
/ statistics & numerical data
Humans
Medical Oncology
/ organization & administration
Middle Aged
Pandemics
/ prevention & control
Patient Acceptance of Health Care
/ statistics & numerical data
Socioeconomic Factors
Telemedicine
/ organization & administration
United States
/ epidemiology
Vulnerable Populations
/ statistics & numerical data
White People
/ statistics & numerical data
COVID-19 pandemic
Health disparities
Social vulnerability index
Telemedicine
Virtual visit
Journal
Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
19
03
2021
accepted:
27
04
2021
pubmed:
18
5
2021
medline:
29
6
2021
entrez:
17
5
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has quickly transformed healthcare systems with expansion of telemedicine. The past year has highlighted risks to immunosuppressed cancer patients and shown the need for health equity among vulnerable groups. In this study, we describe the utilization of virtual visits by patients with gynecologic malignancies and assess their social vulnerability. Virtual visit data of 270 gynecology oncology patients at a single institution from March 1, 2020 to August 31, 2020 was obtained by querying a cohort discovery tool. Through geocoding, the CDC Social Vulnerability Index (SVI) was utilized to assign social vulnerability indices to each patient and the results were analyzed for trends and statistical significance. African American patients were the most vulnerable with a median SVI of 0.71, Asian 0.60, Hispanic 0.41, and Caucasian 0.21. Eighty-seven percent of patients in this study were Caucasian, 8.9% African American, 3.3% Hispanic, and 1.1% Asian, which is comparable to the baseline institutional gynecologic cancer population. The mean census tract SVI variable when comparing patients to all census tracts in the United States was 0.31 (range 0.00 least vulnerable to 0.98 most vulnerable). Virtual visits were utilized by patients of all ages and gynecologic cancer types. African Americans were the most socially vulnerable patients of the cohort. Telemedicine is a useful platform for cancer care across the social vulnerability spectrum during the pandemic and beyond. To ensure continued access, further research and outreach efforts are needed.
Identifiants
pubmed: 33994014
pii: S0090-8258(21)00357-7
doi: 10.1016/j.ygyno.2021.04.037
pmc: PMC8111476
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4-11Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001436
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflicts of interest.
Références
Gynecol Oncol. 2015 Oct;139(1):172-7
pubmed: 26151077
Gynecol Oncol. 2016 Dec;143(3):611-616
pubmed: 27697287
J Breast Cancer. 2020 Oct 19;23(5):542-552
pubmed: 33154829
Cochrane Database Syst Rev. 2015 Sep 07;(9):CD002098
pubmed: 26343551
Asia Pac J Clin Oncol. 2014 Sep;10(3):200-4
pubmed: 24934093
JAMA Oncol. 2021 Apr 1;7(4):597-602
pubmed: 33410867
Gynecol Oncol. 2020 Jul;158(1):16-24
pubmed: 32386911
Gynecol Oncol. 2018 Apr;149(1):70-77
pubmed: 29605053
Ann Surg. 2021 Dec 1;274(6):881-891
pubmed: 33351455
Cancer. 2020 Sep 1;126(17):4023-4031
pubmed: 32573776
Curr Oncol. 2010 Jun;17(3):17-27
pubmed: 20567623
J Med Internet Res. 2017 Jan 09;19(1):e11
pubmed: 28069561
J Surg Oncol. 2014 Sep;110(4):353-9
pubmed: 24889208
J Telemed Telecare. 2018 Apr;24(3):157-167
pubmed: 28081664
Ann Surg Oncol. 2021 Apr;28(4):1918-1926
pubmed: 33057860
J Natl Cancer Inst. 2011 Nov 2;103(21):1566-8
pubmed: 22010180
J Oncol Pract. 2012 Mar;8(2):68
pubmed: 29447100
Rural Remote Health. 2019 Aug;19(3):5269
pubmed: 31412701
Aust J Rural Health. 2012 Oct;20(5):259-64
pubmed: 22998200
Obstet Gynecol Clin North Am. 2020 Jun;47(2):271-285
pubmed: 32451018
Gynecol Oncol. 2017 Jul;146(1):3-10
pubmed: 28372871
Gynecol Oncol Rep. 2021 May;36:100708
pubmed: 33521218
Obstet Gynecol. 2015 Apr;125(4):843-851
pubmed: 25751197
Gynecol Oncol. 2020 Aug;158(2):256-261
pubmed: 32482336